FDA approves Bristol Myers’ Opdivo Qvantig
The Food and Drug Administration announced it has approved nivolumab and hyaluronidase-nvhy, Opdivo Qvantig, from Bristol Myers (BMY) Squibb, ...
BeiGene Announces FDA Approval Of TEVIMBRA - Quick Facts
BeiGene (BGNE) announced the FDA has approved TEVIMBRA, in combination with platinum and fluoropyrimidine-based chemotherapy, for the ...
Medpage Today on MSN2 天
Metastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?'
Metastatic cancer "thrivers" offer hope and inspiration to others with cancer. (Washington Post) A California court ordered ...
Musk upgrades to ‘King Kong’ of weight-loss drugs
Elon Musk has revealed he has upgraded from Ozempic to Mounjaro, nicknamed the “King Kong” of weight-loss drugs, in a photo ...
FDA Approves Generic GLP-1 Medicine For Diabetes Treatment
THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of ...
The Supreme Court enters its teenager era
Like millions of American teens, Kailey Corum is savvy about the dangers of TikTok – but she’s also wary about government ...
The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see ...
The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...
Alaska Dispatch News5 天
FDA says a decongestant in many cold medicines doesn’t work. So what does?
WASHINGTON — Changes are coming to the cold and cough aisle of your local pharmacy: U.S. officials are moving to phase out ...
Grand Rapids' river restoration project moves forward with critical EGLE permit approval
The approval of the permit gives the city the opportunity to begin bidding for the construction contract. The construction is ...
There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea
“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” Dr. Sally Seymour ...
Le Lézard6 天
Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With ...
Zura Bio Limited ("Zura Bio"), a clinical stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today announced the launch of ...